Article
[Influence of FcγRIIIa polymorphism on rituximab-dependent NK cell-mediated cytotoxicity to Raji cells].
Zhongguo shi yan xue ye xue za zhi - 1 Oct 2010
Qu Yu-Hua, Li Yang, Wu Yan-Feng, Fang Jian-Pei, Huang Shao-Liang, Huang Yan, Wei Jing
Abstract excerpt
Fcgamma receptor IIIa (FcγRIIIa) polymorphisms is considered to influence clinical response to therapeutic monoclonal antibody (McAb) in cancer, most people believe it can affect McAb binding, and McAb-dependent NK cell-mediated cytotoxicity. This study was purposed to determine the difference of antibody-dependent cell-mediated cytotoxicity (ADCC) effects mediated by different FcγRIIIa NK cells. The FcγRIIIa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
